| The Pharmaceutical Journal |
|
News summary |
|
Related websites |
Patients with coronary heart disease should consider fish oil supplementsPatients with coronary heart disease (CHD) should consume one serving of oily fish or three fish oil supplement capsules a day, according to new recommendations from the American Heart Association. The AHA already advises that everyone should eat at least two servings of fish each week but has now expanded its guidance to include recommendations for patients with documented CHD and for patients with raised triglyceride levels. Dr Penny Kris-Etherton, professor of nutrition at Pennsylvania State University, and Dr William Harris, from the AHA nutrition committee, put forward the recommendations at the AHA annual scientific sessions held in Chicago earlier this week. They said that people with CHD should consume 1g of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) every day. Patients with raised triglyceride levels should consume 2–4g of EPA/DHA per day. The AHA says that a dietary approach to increasing omega-3 fatty acids is preferable but acknowledges that for patients with CHD or raised triglyceride levels these doses may be greater than can be readily achieved through diet alone. "For these individuals who cannot or will not eat fish the evidence supports the use of supplements to decrease the risk of heart disease and stroke," Dr Harris said. Dr Harris pointed out that most fish oil supplements contain about 0.3g of EPA/DHA, so three capsules would be needed to approximate the recommended daily dose for patients with CHD. He added that one capsule of Omacor, launched last week in the United Kingdom (PJ, 16 November, p700), provides 1g of EPA/DHA. The recommendations are also published this week in Circulation (2002; 106:2747).
|
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal